Table 1.
Abundance of microplastics in human organ systems
| System | Organ | Sample Size | Abundance of microplastics | Size of Microplastics | Shape of Microplastics | Colour of microplastics | Polymer of Microplastics | References |
|---|---|---|---|---|---|---|---|---|
| Cardiovascular system | Blood vessels |
22 |
1.6 ug/mL |
>700 nm |
NA |
NA |
PET, PE, PS, EPS, ABS, PMMA |
[17] |
| Thrombi |
26 |
87 particles |
2.1–26.0 μm |
Block shaped |
Yellow, green, red |
LDPE, Pigment, Chromium Oxide, Phthalocyanine |
[18] |
|
| Vein |
5 |
20 particles or 14.99 ± 17.18 microplastic/g of tissue |
16–1074 μm |
Fragment, fibre |
NA |
Alkyd Resin, Poly(vinyl propionate), Nylon-ethylene-vinyl acetate, nylon-EVA, tie layer |
[19] |
|
|
|
Heart |
15 |
NA |
20–500 μm |
NA |
NA |
PET, PVC, PMMA |
[20] |
| Digestive system | Colorectal cancer tissue |
11 |
331 Microplastics per individual or 28.1–15.4 particles/g tissue |
0.8–1.6 mm |
Fibre |
Transparent, black, red, green, blue, brown, purple, and yellow |
PC, PA, PP |
[21] |
|
|
Liver |
11 |
0–13 particles per sample or 3.2 particles/g tissue |
4–30 μm |
Fragment, microbead |
NA |
PS, PVC, PET, PMMA, POM, PP |
[22] |
| Endocrine system | Placenta |
NA |
12 particles |
>5 μm |
Fragment |
Blue, purple, pink, orange, red |
PP |
[23] |
| Placenta |
|
NA |
>50 μm |
NA |
|
PE, PP, PU |
[24] |
|
| Placenta |
17 |
149 microplastics particles |
20.34–307.24 μm |
Fragment, fibre, film, subspherical particle |
NA |
PVC, PP, PBS, PET, PC, PS, PA, PE, PSF |
[25] |
|
|
|
Placenta |
18 |
NA |
20–500 μm |
NA |
NA |
PU, PA, PE, PET, PC |
[26] |
| Integumentary system | Face skin |
2000 |
4265 microplastics particles |
100–500 μm |
Spheres fragment, film, fibre |
Blue, red, yellow, transparent, black |
PE, PET, PS, PVC |
[27] |
| Hand skin |
2000 |
4051 microplastics particles |
100–500 μm |
Sphere, fragment, film, fibre |
Blue, red, yellow, transparent, black |
PE, PET, PS, PVC |
[27] |
|
| Hair |
2000 |
7462 microplastics particles |
100–500 μm |
Sphere, fragment, film, fibre |
Blue, red, yellow, transparent, black |
PE, PET, PS, PVC |
[27] |
|
|
|
Saliva |
2000 |
645 microplastics particles |
100–500 μm |
Sphere, fragment, film, fibre |
Blue, red, yellow, transparent, black |
PE, PET, PS, PVC |
[27] |
| Lymphatic system |
Spleen |
3 |
4 particles per sample or 1.1 particles/g tissue |
5–25 μm |
Fragment, Microbead |
NA |
PS, PVC, PET, PMMA, POM, PP |
[22] |
| Respiratory system | Lung tissues |
20 |
31 particles |
1.6–16.8 μm |
Fragment, fibre |
Transparent, white, blue, grey, yellow, brown, orange |
PP, PE, Cotton, PVC, CA, PA, PS, PU |
[28] |
| Lung granule nodules |
100 |
65 particles |
>20 μm |
Fibre |
Purple, blue, transparent, yellow, red |
Cotton, PA, Polyester, Denim, Phenoxy resin, |
[29] |
|
|
|
Lung tissue |
13 |
39 particles |
12–2475 μm |
Fibre, fragment, film |
NA |
PP, PET, Resin, PE, PTFE, PS, PAN, PES, PMMA, PUR, SEBS, TPE |
[30] |
| Reproductive system |
Testis |
6 |
31 particles in 4 of 6 testis samples |
20–100 μm |
Fragment, fibre, film, subspherical |
NA |
PS, PVC, PE, PP |
[31] |
| Urinary system | Kidney | 3 | 0 particle per sample | 10–20 μm | NA | NA | NA | [22] |
ABS – Acrylonitrile Butadiene Styrene, CA – Cellulose Acetate, CPE – Chlorinated Polyethylene, EPS – Expanded Polystyrene, EVA – Ethylene-Vinyl Acetate, HDPE – High-Density Polyethylene, LDPE – Low Density Polyethylene, NA – not available, NC – Nitrocellulose, mm – millimetre, PA – Polyamide, PAN – Polyacrylonitrile, PBS – Phosphate-buffered Saline, PBT – Persistent Bioaccumulative Toxic, PES – Polyethersulfone, PET – Polyethylene Terephthalate, PEMA – Phenylethylmalonamide, PC – Polycarbonate, PLA – Polylactic acid, PMMA – Polymethyl methacrylate, POM – Polyoxymethylene, PP – Polypropylene, PS – Polystyrene, PSF/PSU – Polysulfone, PU/PUR – Polyurethane, PTFE – Polytetrafluoroethylene, PVC – Polyvinyl Chloride, PVOH – Polyvinyl Alcohol, TPE – Thermoplastic Elastomere, SEBS – Styrene-Ethylene-Butylene-Styrene, μm – micrometre, μg/mL – microgram per millilitre